NCT03508960Recruiting
Chinese EOPD Registry
The Chinese Early-onset Parkinson's Disease Registry
Source: ClinicalTrials.gov · Last updated 11 May 2018 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a database of persons with early-onset Parkinson's disease (EOPD) in China.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 11 Apr 2018
- Start date
- 1 Feb 2017
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Xiangya Hospital of Central South University
- Diseases
- Parkinson disease
- NCT number
- NCT03508960
What you commit to
- Study type: Observational
- Planned participants: 3000
- From 1 Feb 2017 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients have a family history of PD.
Who the study is looking for
- Patients diagnosed with PD by UKBB and other standard criteria Age of onset is no more than 50 years old.
Age in the registry: - to 50 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.